Abbott Labs CDR (CAD Hedged) (ABT)
Cboe Canada · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 18.03 |
|---|---|
| 52-week range | 14.46 – 23.32 |
| Return, 1 month / 3 months | +2.9% / −1.8% |
| Return, 1 year / 3 years | −18.6% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 29.4% |
| Worst drawdown (1 year) | -38.3% |
| Average daily value traded | 0.09M CAD |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Abbott Labs CDR (CAD Hedged) (ABT) trades on the Cboe Canada in Canada. It last closed at CAD 18.03 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 79 of 164 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.6% and over the last three months it fell 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Cboe Canada
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | -22.7% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.8% | ||
| 6-month return | 11.5% | ||
| 12-month return, skipping the last month | -20.9% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.3% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M CAD | ||
| Zero-volume days | 1.7% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.4% |
|---|---|
| 1 month | +2.9% |
| 3 months | −1.8% |
| 6 months | +11.5% |
| 1 year | −18.6% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 18.41 / 17.97 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | USD 0.1097 |
| 15 Jul 2026 | USD 0.1102 |
| 15 Apr 2026 | USD 0.1104 |
| 15 Jan 2026 | USD 0.1087 |
| 15 Oct 2025 | USD 0.1046 |
| 15 Jul 2025 | USD 0.1062 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Cboe Canada; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.